U.S. Markets closed

A Look at GlaxoSmithKline’s Valuation on May 29

Mike Benson
A Look at GlaxoSmithKline’s Valuation on May 29

GlaxoSmithKline (GSK) is focused on maintaining a sustainable growth model by strategizing its business beyond pharmaceuticals.